The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Open accessAbstract
Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, activation of pyruvate kinase can inhibit cancer cell proliferation and tumor growth in some settings (Anastasiou et al., 2012; Kung et al., 2012; Walsh et al., 2010), but because pyruvate kinase expression is dispensable for the growth of some tumors (Cortes-Cros et al., 2013; Israelsen et al., 2013), whether pyruvate kinase activation will lead to durable responses remains an area of”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Anastasiou et al., 2012
In the citing paper
“Activating PKM2 by using small-molecule agonists increases PEP-to-pyruvate conversion, reducing the flux of glycolytic intermediates toward anabolic pathways and slowing tumor cell growth (56, 60).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“PKM2 exists as either an inactive dimer or an active tetramer, and oscillation between these two states influences the ability of cells to maintain anabolic metabolism (56).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“In order to examine the functional relevance of PKM2 for LPS action we next examined the effect of two highly specific small-molecule PKM2 activators, TEPP-46 and DASA-58.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“TEPP-46, but not DASA-58, is pharmacokinetically validated in vivo (Anastasiou et al., 2012).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“These well-characterized and highly specific compounds bind PKM2, which then forms a tight tetramer with PKM1-like kinetic properties, an event that is resistant to inhibition by tyrosine phosphorylation.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationRefinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,837
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 830
How DNA methylation affects the Warburg effect
Zhu, X., Xuan, Z., Chen, J., Li, Z., Zheng, S., & Song, P. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45420 · Cited by 42
Almouhanna, F., Blagojevic, B., Can, S., Ghanem, A., & Wölfl, S. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00239-8 · Cited by 40
Irokawa, H., Numasaki, S., Kato, S., Iwai, K., Inose-Maruyama, A., Ohdate, T., Hwang, G., Toyama, T., Watanabe, T., & Kuge, S. (2021) · Biochemical Journal · doi:10.1042/bcj20200897 · Cited by 42
Wang, Y., Shu, H., Liu, J., Jin, X., Wang, L., Qu, Y., Xia, M., Peng, P., Feng, Y., & Wei, M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102340 · Cited by 43
Huang, L., Yu, Z., Zhang, T., Zhao, X., & Huang, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092949 · Cited by 39
Yan, M., Chakravarthy, S., Tokuda, J. M., Pollack, L., Bowman, G. D., & Lee, Y. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00658 · Cited by 39
Tanaka, F., Yoshimoto, S., Okamura, K., Ikebe, T., & Hashimoto, S. (2018) · Oncotarget · doi:10.18632/oncotarget.25850 · Cited by 38
Papadaki, C., Manolakou, S. D., Lagoudaki, E. D., Pontikakis, S., Ierodiakonou, D., Vogiatzoglou, K., Messaritakis, I., Trypaki, M., Giannikaki, L., Sfakianaki, M., et al. (2020) · Cancers · doi:10.3390/cancers12041013 · Cited by 39
Modulation of PKM Activity Controls Differentiation of Th17 Cells
Seki, S. M., Posyniak, K., McCloud, R. L., Rosen, D. A., Fernández-Castañeda, A., Beiter, R. M., Serbulea, V., Nanziri, S. C., Hayes, N. W., Spivey, C., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aay9217 · Cited by 38
Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
Veras, F. P., Públio, G. A., de Melo, B. M. S., Prado, D. D. S., Norbiato, T., Cecílio, N. T., Hiroki, C. H., Damasceno, L. E. A., Jung, R., Toller-Kawahisa, J. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111897 · Cited by 38
Miao, G., Han, J., Zhang, J., Wu, Y., & Guanhe, T. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00730 · Cited by 38
Molecular determinants as therapeutic targets in cancer chemotherapy: An update
Haider, T., Tiwari, R., Vyas, S. P., & Soni, V. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.011 · Cited by 38
Protein homodimer sequestration with small molecules: Focus on PD-L1
Bailly, C., & Vergoten, G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113821 · Cited by 38
Oxidative Stress and Inflammation Can Fuel Cancer
Vaidya, F. U., Chhipa, A. S., Sagar, N., & Pathak, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-1568-2_14 · Cited by 37
Li, X., Jiang, Y., Zhang, X., Wang, X., Wei, R., Qin, K., & Lu, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03400-9 · Cited by 37
Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities
Qu, H., Liu, J., Zhang, D., Xie, R., Wang, L., & Hong, J. (2023) · Cells · doi:10.3390/cells12151930 · Cited by 36
Advances in macrophage metabolic reprogramming in myocardial ischemia-reperfusion
Ao-Di, F., Han-Qing, L., Xi-Zheng, W., Yang, K., Hong-Xin, G., Hai-xia, Z., Guan-Wei, F., & Li-Lan (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111370 · Cited by 38
Ahuja, S., & Zaheer, S. (2025) · Immunology · doi:10.1111/imm.70045 · Cited by 43
Li, X., Wang, X., Wang, X., Liu, S.-H., Ding, X., Chen, G., & Lu, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737056 · Cited by 36
Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment
Rihan, M., Nalla, L. V., Dharavath, A., Shard, A., Kalia, K., & Khairnar, A. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00226-0 · Cited by 39
Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection
Abudula, A., Rouzi, N., Xu, L., Yang, Y., & Hasimu, A. (2019) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2019.4359 · Cited by 38
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
Coleman, M. F., Cozzo, A. J., Pfeil, A. J., Etigunta, S. K., & Hursting, S. D. (2020) · Cancers · doi:10.3390/cancers12040852 · Cited by 37
TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation
Gao, F., Zhang, X., Wang, S., Zheng, L., Sun, Y., Wang, G., Song, Z., & Bao, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03782-w · Cited by 35
Reprogramming of central carbon metabolism in hepatocellular carcinoma
Xia, H., Huang, Z., Xu, Y., Yam, J. W. P., & Cui, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113485 · Cited by 40
Wu, H., Guo, X., Jiao, Y., Wu, Z., & Lv, Q. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5434 · Cited by 36
Metabolic response to radiation therapy in cancer
Read, G. H., Bailleul, J., Vlashi, E., & Kesarwala, A. H. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23379 · Cited by 41
Schoepflin, Z. R., Silagi, E. S., Shapiro, I. M., & Risbud, M. V. (2017) · The FASEB Journal · doi:10.1096/fj.201601291r · Cited by 35
Richardson, D. A., Sritangos, P., James, A. D., Sultan, A. M., & Bruce, J. I. E. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-0210-2 · Cited by 36
Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2
Nandi, S., & Dey, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013030 · Cited by 35
Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses
Walls, J. F., Subleski, J. J., Palmieri, E. M., Gonzalez-Cotto, M., Gardiner, C. M., McVicar, D. W., & Finlay, D. K. (2020) · eLife · doi:10.7554/elife.59166 · Cited by 35
Dual roles of β-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer
Yu, H., Wang, M., Zhang, T., Cao, L., Li, Z., Du, Y., Hai, Y., Gao, X., Ji, J., & Wu, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123231119 · Cited by 36
Mukherjee, J., Ohba, S., See, W. L., Phillips, J. J., Molinaro, A. M., & Pieper, R. O. (2016) · International Journal of Cancer · doi:10.1002/ijc.30041 · Cited by 36
Yu, Z., Huang, L., Qiao, P., Jiang, A., Wang, L., Yang, T., Tang, S., Zhang, W., & Ren, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.160 · Cited by 35
Structures of pyruvate kinases display evolutionarily divergent allosteric strategies
Morgan, H. P., Zhong, W., McNae, I. W., Michels, P. A. M., Fothergill‐Gilmore, L. A., & Walkinshaw, M. D. (2014) · Royal Society Open Science · doi:10.1098/rsos.140120 · Cited by 36
Kim, D. J., Park, Y. S., Kim, N. D., Min, S. H., You, Y.-M., Jung, Y., Koo, H., Noh, H., Kim, J., Park, K. C., et al. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.2314 · Cited by 34
Iacobini, C., Vitale, M., Pugliese, G., & Menini, S. (2021) · Biomedicines · doi:10.3390/biomedicines9091139 · Cited by 37
Ding, Z., Da, H., Osama, A., Xi, J., Hou, Y., & Fang, J. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112790 · Cited by 34
Yoon, Y. J., Kim, Y. H., Jin, Y., Chi, S., Moon, J. H., Han, D. C., & Kwon, B. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.015 · Cited by 32
A critical review of the role of M2PYK in the Warburg effect
Harris, R. A., & Fenton, A. W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.004 · Cited by 32
Heterogeneity of Glucose Transport in Lung Cancer
Martinez, C. A., & Scafoglio, C. (2020) · Biomolecules · doi:10.3390/biom10060868 · Cited by 35
Zhou, J., Su, C.-M., Chen, H.-A., Du, S., Li, C., Wu, H., Tsai, S., & Yeh, Y.-T. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s239134 · Cited by 33
Bailleul, J., Ruan, Y., Abdulrahman, L., Scott, A. J., Yazal, T., Sung, D., Park, K., Hoang, H., Nathaniel, J., Chu, F., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad103 · Cited by 32
Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapy
Kee, H. J., & Cheong, J. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.273 · Cited by 32
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 32
An engineered photoswitchable mammalian pyruvate kinase
Gehrig, S. M., Macpherson, J. A., Driscoll, P. C., Symon, A., Martin, S. R., MacRae, J. I., Kleinjung, J., Fraternali, F., & Anastasiou, D. (2017) · FEBS Journal · doi:10.1111/febs.14175 · Cited by 33
Self-citationMetabo-Devo: A metabolic perspective of development
Gándara, L., & Wappner, P. (2018) · Mechanisms of Development · doi:10.1016/j.mod.2018.02.004 · Cited by 31
Liu, B., Yuan, X., Xu, B., Zhang, H., Li, R., Wang, X., Ge, Z., & Li, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.003 · Cited by 31
Bi, Y.-H., Han, W., Li, R., Wang, Y., Du, Z., Wang, X.-J., & Jiang, Y. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i16.1936 · Cited by 33
Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma
Tech, K., Deshmukh, M., & Gershon, T. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.017 · Cited by 31
Dayton, T. L., Gocheva, V., Miller, K. M., Bhutkar, A. J., Lewis, C. A., Bronson, R. T., Heiden, M. G. V., & Jacks, T. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0179-2 · Cited by 34
Serra, M., Matteo, M. D., Serneels, J., Pal, R. R., Cafarello, S. T., Lanza, M., Sànchez‐Martìn, C., Evert, M., Castegna, A., Calvisi, D. F., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.06.003 · Cited by 31
PKM2 activation sensitizes cancer cells to growth inhibition by 2-deoxy-D-glucose
Tee, S. S., Park, J. M., Hurd, R. E., Brimacombe, K. R., Boxer, M. B., Massoud, T. F., Rutt, B. K., & Spielman, D. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19630 · Cited by 34
Self-citationHuang, K., Jiang, L., Liang, R., Li, H., Ruan, X., Shan, C., Ye, D., & Zhou, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.085 · Cited by 31
Sun, X., Yao, L., Liang, H., Wang, D., He, Y., Yao, W., Ye, L., Wang, K., Li, L., Chen, J., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0197-6 · Cited by 31
Shen, M.-Y., Di, Y., Wang, X., Tian, F.-X., Zhang, M.-F., Qian, F., Jiang, B., Zhou, X., & Zhou, L. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2023.2173248 · Cited by 30
Self-citationEffects of glycolysis on the polarization and function of tumor‑associated macrophages (Review)
Cao, J., Zeng, F., Liao, S., Cao, L., & Zhou, Y. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5518 · Cited by 34
Márquez, S., Fernández, J. J., Mancebo, C., Herrero-Sánchez, C., Alonso, S., Sandoval, T. A., Rodríguez-Prados, M., Cubillos‐Ruiz, J. R., Montero, O., Fernández, N., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.033 · Cited by 33
Chen, T., Wang, H., Liu, J.-S., Cheng, H.-H., Hsu, S.-C., Wu, M.-C., Lu, C., Wu, Y.-F., Wu, J.-W., Liu, Y.-Y., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0343-4 · Cited by 30
Role of Pyruvate Kinase M2 (PKM2) in Cardiovascular Diseases
Rihan, M., & Sharma, S. S. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10321-1 · Cited by 30
Matsui, Y., Yasumatsu, I., Asahi, T., Kitamura, T., Kanai, K., Ubukata, O., Hayasaka, H., Takaishi, S., Hanzawa, H., & KATAKURA, S. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.004 · Cited by 31
The interaction between apigenin and PKM2 restrains progression of colorectal cancer
Shi, J., Ji, X., Shan, S., Zhao, M., Bi, C., & Li, Z. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109430 · Cited by 29
Lin, M., Huang, L., Huang, J., Yu, J., Yang, X., & Yang, J. Y. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103198 · Cited by 30
Zhou, Z., Zheng, X., Zhao, J., Yuan, A., Lv, Z., Shao, G.-C., Peng, B., Dong, M., Xu, Q., Xu, X., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03035-y · Cited by 31
Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator
Chen, T., Wu, C., Hung, M., Wang, W., & Kung, H.-J. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01170-6 · Cited by 29
Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
Wang, S., Zhou, D., Xu, Z., Song, J., Qian, X., Lv, X., & Luan, J. (2019) · Current Drug Targets · doi:10.2174/1389450120666190402145325 · Cited by 29
TEPP-46-Based AIE Fluorescent Probe for Detection and Bioimaging of PKM2 in Living Cells
Wang, D., Li, C., Zhu, Y., Song, Y., Lu, S., Sun, H., Hao, H., & Xu, X. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02529 · Cited by 29
PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
Boschert, V., Teusch, J., Müller-Richter, U. D. A., Brands, R. C., & Hartmann, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020775 · Cited by 29
Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
El‐Far, A. H., Jaouni, S. K. A., Li, X., & Fu, J. (2022) · Phytotherapy Research · doi:10.1002/ptr.7534 · Cited by 29
Targeting energy metabolism to eliminate cancer cells
Shahruzaman, S. H., Fakurazi, S., & Maniam, S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167424 · Cited by 29
Glycolytic side pathways regulating macrophage inflammatory phenotypes and functions
Dionísio, F., Tomas, L., & Schulz, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00276.2022 · Cited by 30
Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance
Stouras, I., Vasileiou, M., Kanatas, P., Tziona, E., Tsianava, C., & Theocharis, S. (2023) · Cells · doi:10.3390/cells12232686 · Cited by 29
Yu, S., Pei, S., Zhang, M., Gao, S., Chen, J., Duan, L., Hu, E., Wang, Y., & Huang, Y. (2024) · Communications Biology · doi:10.1038/s42003-024-07227-w · Cited by 28
Metabolic implication of tumor:stroma crosstalk in breast cancer
Morandi, A., & Chiarugi, P. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1124-7 · Cited by 29
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
Valentin-Guillama, G. A., Acevedo, S. N. L., Kucheryavykh, Y. V., Chorna, N., Pérez, J., Ortiz-Rivera, J., Inyushin, M. Y., Makarov, V. I., Valentín-Acevedo, A., Quiñones‐Hinojosa, A., et al. (2018) · Cancers · doi:10.3390/cancers10090301 · Cited by 28
Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors
Hsieh, I., Gopula, B., Chou, C., Wu, H.-Y., Chang, G., Wu, W., Chang, C., Chu, P., & Chen, C. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00763 · Cited by 28
Pastore, M., Lori, G., Gentilini, A., Taddei, M. L., Maira, G. D., Campani, C., Recalcati, S., Invernizzi, P., Marra, F., & Raggi, C. (2020) · Cells · doi:10.3390/cells9030596 · Cited by 28
Ding, Z., Xi, J., Zhong, M., Chen, F., Zhao, H., Zhang, B., & Fang, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05394 · Cited by 27
Yang, Y., Zhan, X., Zhang, C., Shi, J., Wu, J., Deng, X., Xing, X., Cheng, A., Yu, H., Wang, Y.-N., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109279 · Cited by 27
Das, M., Bag, A. K., Saha, S., Ghosh, A., Dey, S. K., Das, P., Mandal, C., Ray, S., Chakrabarti, S., Ray, M., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2172-x · Cited by 27
Jiang, L., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/489511a · Cited by 29
Ge, X., Zhao, Y., Dong, L., Jingjing, S., Zhang, X., & Dou, D. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28910 · Cited by 27
Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
Demeure, K., Fack, F., Duriez, E., Tiemann, K., Bernard, A., Golebiewska, A., Bougnaud, S., Bjerkvig, R., Domon, B., & Niclou, S. P. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.052423 · Cited by 28
Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer
Chávez‐González, A., Bakhshinejad, B., Pakravan, K., Guzmán, M. L., & Babashah, S. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0297-1 · Cited by 26
Sun, Y., Luo, M., Chang, G., Ren, W., Wu, K., Li, X., Shen, J., Zhao, X., & Hu, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.7085 · Cited by 26
PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation
Zhang, L., Bailleul, J., Yazal, T., Dong, K., Sung, D., Dao, A., Gosa, L., Nathanson, D., Bhat, K., Duhachek-Muggy, S., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05376-9 · Cited by 28
Masaki, S., Hashimoto, K., Kihara, D., Tsuzuki, C., Kataoka, N., & Suzuki, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.182 · Cited by 26
Long, L., Chen, M., Yuan, Y. J., Ming, A. L., Guo, W., Wu, K., & Chen, H. (2020) · Journal of Cancer · doi:10.7150/jca.42610 · Cited by 27
Li, L., Peng, G., Liu, X., Zhang, Y., Han, H., & Liu, Z. (2020) · iScience · doi:10.1016/j.isci.2020.101684 · Cited by 27
HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma
Huang, J., Zhao, X., Li, X., Peng, J., Yang, W., & Mi, S. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001197 · Cited by 26
Predicting allosteric pockets in protein biological assemblages
Kumar, A., Kaynak, B., Dorman, K. S., Doruker, P., & Jernigan, R. L. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad275 · Cited by 26
He, G., Chen, C., Wang, T., Wu, F., Ouyang, L., Xiang, M., Jiang, Q., Huang, W., & Peng, C. Y. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s62921 · Cited by 28
Cancer‐associated mutations in human pyruvate kinase M2 impair enzyme activity
Liu, V. M., Howell, A. J., Hosios, A. M., Li, Z., Israelsen, W. J., & Heiden, M. G. V. (2019) · FEBS Letters · doi:10.1002/1873-3468.13648 · Cited by 26
Self-citationPatel, C. B., Beinat, C., Xie, Y., Chang, E., & Gambhir, S. S. (2020) · Neoplasia · doi:10.1016/j.neo.2020.11.003 · Cited by 26
Metabolomics and cellular altered pathways in cancer biology: A review
Bhardwaj, J. K., Siwach, A., & Sachdeva, S. N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23807 · Cited by 27
Kim, H., Takegahara, N., & Choi, Y. (2023) · Bone Research · doi:10.1038/s41413-023-00251-2 · Cited by 22
Ventouri, I. K., Veelders, S., Passamonti, M., Endres, P., Roemling, R., Schoenmakers, P. J., Somsen, G. W., Haselberg, R., & Gargano, A. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341324 · Cited by 28
Lockney, N. A., Zhang, M., Lu, Y., Sopha, S. C., Washington, M. K., Merchant, N. B., Zhao, Z., Shyr, Y., Chakravarthy, A. B., & Xia, F. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9764-6 · Cited by 25
Dichloroacetate affects proliferation but not survival of human colorectal cancer cells
Delaney, L. M., Ho, N., Morrison, J. A., Farias, N., Mosser, D. D., & Coomber, B. L. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1046-4 · Cited by 26
Ahmed, K. A., & Chinnaiyan, P. (2014) · Metabolites · doi:10.3390/metabo4030740 · Cited by 26
Hyperpolarized Sodium [1-13C]-Glycerate as a Probe for Assessing Glycolysis In Vivo
Park, J. M., Wu, M., Datta, K., Liu, S.-C., Castillo, A., Lough, H., Spielman, D. M., & Billingsley, K. L. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b00708 · Cited by 28
Metadata
- Authors
- Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., Yang, H., Mattaini, K. R., Metallo, C. M., Fiske, B. P., Courtney, K. D., Malstrom, S., Khan, T. M., Kung, C., Skoumbourdis, A. P., Veith, H., Southall, N., Walsh, M. J., Brimacombe, K. R., Leister, W., Lunt, S. Y., Johnson, Z. R., Yen, K. E., Kunii, K., Davidson, S. M., Christofk, H. R., Austin, C. P., Inglese, J., Harris, M. H., Asara, J. M., Stephanopoulos, G., Salituro, F. G., Jin, S., Dang, L., Auld, D. S., Park, H.-W., Cantley, L. C., Thomas, C. J., & Vander Heiden, M. G.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Massachusetts Institute of Technology (US)
- National Institutes of Health (US)
- University of Toronto (CA)
- Agios Pharmaceuticals (United States) (US)
- University of California San Diego (US)
- Boston Children's Hospital (US)
- ORCID
- Anastasiou, Dimitrios
- Yu, Yimin
- Israelsen, William J
- Jiang, Jian-Kang
- Tempel, Wolfram
- Shen, Min
- Jha, Abhishek
- Yang, Hua
- Mattaini, Katherine R
- Metallo, Christian M
- Fiske, Brian P
- Courtney, Kevin D
- Khan, Tahsin M
- Southall, Noel
- Walsh, Martin J
- Brimacombe, Kyle R
- Lunt, Sophia Y
- Johnson, Zachary R
- Yen, Katharine E
- Kunii, Kaiko
- Davidson, Shawn M
- Christofk, Heather R
- Austin, Christopher P
- Inglese, James
- Harris, Marian H
- Asara, John M
- Stephanopoulos, Gregory
- Salituro, Francesco G
- Dang, Lenny
- Auld, Douglas S
- Park, Hee-Won
- Cantley, Lewis C
- Thomas, Craig J
- Venue
- Nature Chemical Biology
- Published
- 2012-08-26
- Volume
- 8
- Issue
- 10
- Pages
- 839-847
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC3711671
- OpenAlex
- W2125836344
- Cited by
- 816
- References
- 46
- Citations by year
- 2026: 39 · 2025: 76 · 2024: 61 · 2023: 66 · 2022: 59 · 2021: 73 · 2020: 69 · 2019: 47 · 2018: 60 · 2017: 49 · 2016: 53 · 2015: 55 · 2014: 55 · 2013: 45 · 2012: 9
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-11-26)
- Open access
- green
- europepmc.org
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- University of Chicago
- Genome Canada
- Wellcome Trust
- Knut och Alice Wallenbergs Stiftelse
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Mental Health (R03MH085679)
- National Cancer Institute (5P30CA1405141, R01CA160458, P01CA120964, P30CA006516)
- National Institute of General Medical Sciences (R01 GM56203, R01GM056203)
- Biological and Environmental Research
- Argonne National Laboratory
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- PKM2, tetramerization, fructose-1,6-bisphosphate, small molecule activators, PKM1, tumor growth inhibition, tumor xenografts, cancer metabolism, glucose metabolism, tyrosine phosphorylation, anabolic metabolism, enzyme activation
- MeSH terms
- Animals, Biopolymers, Cell Transformation, Neoplastic, Humans, Neoplasms, Pyruvate Kinase, Blotting, Western, Enzyme Activators, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
